Kranz, Lena M.
Diken, Mustafa
Haas, Heinrich
Kreiter, Sebastian
Loquai, Carmen
Reuter, Kerstin C.
Meng, Martin
Fritz, Daniel
Vascotto, Fulvia
Hefesha, Hossam
Grunwitz, Christian
Vormehr, Mathias
Hüsemann, Yves
Selmi, Abderraouf
Kuhn, Andreas N.
Buck, Janina
Derhovanessian, Evelyna
Rae, Richard
Attig, Sebastian
Diekmann, Jan
Jabulowsky, Robert A.
Heesch, Sandra
Hassel, Jessica
Langguth, Peter
Grabbe, Stephan
Huber, Christoph
Türeci, Özlem
Sahin, Ugur
Article History
Received: 28 December 2015
Accepted: 6 May 2016
First Online: 1 June 2016
Change Date: 7 June 2016
Change Type: Correction
Change Details: The competing financial interests statement did not display correctly online when this paper was first published; this has been corrected and the statement is now available.
Competing interests
: U.S., H.H, M.M., D.F., K.C.R, C.G., Ho.He, Y.H., M.V., A.N.K., J.B., E.D., J.D., R.J. and S.H. are employees at BioNTech AG (Mainz, Germany). M.D. and S.K. are working as consultants for BioNTech AG (Mainz, Germany). U.S., L.M.K., M.D., H.H., S.K., D.F., M.M. and K.C.R. are inventors on patents and patent applications related to this study. U.S. and C.H are stock owners, C.H. is advisor and supervisory board member and U.S. is management board member of BioNTech AG. All other authors have no potential conflict of interest.